The immune system during the precancer period: naturally-occurring tumor reactive monoclonal antibodies and urethane carcinogenesis - PubMed (original) (raw)
The immune system during the precancer period: naturally-occurring tumor reactive monoclonal antibodies and urethane carcinogenesis
L Agassy-Cahalon et al. Immunol Lett. 1988 Jul.
Abstract
Previous results obtained in our laboratory suggested that natural antibodies reactive with L5178Y lymphoma cells play a role in the induction of lung tumors by the chemical carcinogen urethane. In order to characterize some of the naturally-occurring L5178Y reactive antibodies we prepared hybridomas that secreted natural monoclonal IgM antibodies reactive with L5178Y lymphoma cells. In the present study we characterized some of these antibodies and provided further proof as to their role in urethane carcinogenesis. One hybridoma secreted a cytotoxic antibody that reacted only with mouse lymphoma cell lines. Other non-cytotoxic monoclonal L5178Y-reactive antibodies showed various degrees of cross-reactivity with syngeneic, allogeneic and xenogeneic cells of normal or malignant origin. One of these antibodies reacted much better with activated T cells than with resting ones. Four groups of mice were treated with urethane. Three groups were injected twice a week during 5 months with different IgM preparations of natural monoclonal antibodies. The mice in the fourth group were not treated with IgM and served as controls. Five months after the urethane treatment the mice were sacrificed and the number of tumor foci in the lungs of each mouse was determined. The results show that the group treated with the cytotoxic monoclonal antibody 1.80 had a significant decrease, while the group treated with the IgM myeloma protein 104E had a significant increase in the number of tumor foci compared to urethane-treated mice that did not receive any IgM treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Naturally-occurring tumor-reactive autoantibodies: a monoclonal antibody from normal mice reacts with tumor cells and with DNA.
Smorodinsky NI, Cahalon L, Argov S, Witz IP, Shoenfeld Y. Smorodinsky NI, et al. Immunol Lett. 1988 May;18(1):43-9. doi: 10.1016/0165-2478(88)90068-5. Immunol Lett. 1988. PMID: 3259944 - Studies on the level of natural antibodies reactive with various tumor cells during urethane carcinogenesis in BALB/c mice.
Witz IP, Yaakubowicz M, Gelernter I, Hochberg Y, Anavi R, Ran M. Witz IP, et al. Immunobiology. 1984 Mar;166(2):131-45. doi: 10.1016/S0171-2985(84)80032-7. Immunobiology. 1984. PMID: 6724635 - Do naturally occurring antibodies play a role in the progression and proliferation of tumor cells?
Witz IP, Agassy-Cahalon L. Witz IP, et al. Int Rev Immunol. 1988 Mar;3(1-2):133-45. doi: 10.3109/08830188809051186. Int Rev Immunol. 1988. PMID: 3073177 Review. No abstract available.
Cited by
- Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.
DeNardo DG, Coussens LM. DeNardo DG, et al. Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746. Breast Cancer Res. 2007. PMID: 17705880 Free PMC article. Review. - The interplay between innate and adaptive immunity regulates cancer development.
de Visser KE, Coussens LM. de Visser KE, et al. Cancer Immunol Immunother. 2005 Nov;54(11):1143-52. doi: 10.1007/s00262-005-0702-5. Epub 2005 May 12. Cancer Immunol Immunother. 2005. PMID: 15889249 Free PMC article. Review. - CD5+ B cells and naturally occurring autoantibodies in cancer patients.
Stein R, Witz IP, Ovadia J, Goldenberg DM, Yron I. Stein R, et al. Clin Exp Immunol. 1991 Sep;85(3):418-23. doi: 10.1111/j.1365-2249.1991.tb05742.x. Clin Exp Immunol. 1991. PMID: 1716541 Free PMC article.